ERSRMPC: Use of Motor Rehabilitation Courses in Children With Cerebral Palsy
Study Details
Study Description
Brief Summary
In 2022, the prevalence of Cerebral Palsy (CP) is 2.5 cases per 1000 live births. In France, 125,000 persons are affected by CP. Many treatments and therapies exist to reduce CP-related disorders, but CP remains uncurable. Motor Rehabilitation Courses (MRC) are one of those therapies used with children with CP. Their uses has not been studied in France yet.
The aim of this survey is to find out about the use of motor rehabilitation courses for children with CP and, where appropriate, the content of these courses. This questionnaire will be used to determine the use and different types of MRS in which children participate.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
In total, the questionnaire contains 131 items divided into 13 groups. The estimated filling time is 20 minutes.
The questionnaire is divided as follows:
-
INFORMATION DOCUMENT FOR THE RESEARCH PARTICIPANT
-
About the person with cerebral palsy
-
About the respondent
-
About the usual motor rehabilitation
-
About participation in motor rehabilitation courses
-
-
- Information about MRS
-
- Relationship of care or treatment received to participation in MRS 10) Information about the child 11) Information about the child's environment 12) Additional comments from the respondent regarding the MRS 13) Respondent's opinion on the questionnaire
Study Design
Outcome Measures
Primary Outcome Measures
- Prevalence of the use of motor rehabilitation courses in children with cerebral palsy [Each participant will answer for 20 minutes an expert-validated questionnaire on the internet once recruited in the study]
Prevalence of the use of motor rehabilitation courses
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Child with a diagnosis of cerebral palsy
-
Aged between 6 and 18 years
Exclusion Criteria:
-
Child diagnosed with CP after age 6
-
Between 1 and 6 years of age
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- University Hospital, Grenoble
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 38RC23.0023